A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Stethophone™ Receives Full Approval for Use by Patients and Their Families in Ukraine

Ukraine clears breakthrough SaaMD that enables people to usetheir smartphones as clinical-grade devices that listen for cardiovascular disease at home

Sparrow BioAcoustics today announced it has received clearance from the State Service of Ukraine for Medicines and Drugs Control for its Stethophone™ app to be used by patients and their families, as well as by medical professioinals.

“Sparrow BioAcoustics is proud to receive its first full approval for patients to use Stethophone in Ukraine,” said Mark Opauszky, CEO of Sparrow. “Like many people, members of our team are close to Ukraine and neighboring countries in Eastern Europe. We wanted to be able to help patients in this nation. Like the U.S. Food and Drug Administration, the Ukrainian health authority is known for its high standards and strong focus on public safety.”

Earlier this year, the FDA granted clearance for Stethophone to be used by medical professionals and emergency medical technicians to monitor, record and share the sounds of the heart and lungs. In Sparrow’s clinical tests, Stethophone outperforms the class-leading traditional stethoscopes in cardiac and pulmonary auscultation.

Stethophone is a breakthrough Software as a Medical Device (SaaMD) app that enables smartphones to capture, isolate and evaluate the sounds of the heart and lungs simply by placing the microphone of a smartphone against a patient’s chest. The information is processed for both visual and auditory evaluation, and can be securely shared with other members of the care team. This makes Stethophone the clinical-grade stethoscope that is always with you, and can capture the sounds of symptoms whenever and wherever they occur.

The downloadable Stethophone™ application uses advanced acoustic processing to provide smartphones with highly sensitive cardiac and pulmonary listening capability. Stethophone is unique in that there is nothing new to plug in, charge, or connect. Heart and lung sounds are captured by simply holding a smartphone to a patient’s chest.

“There is a world of diagnostic information contained in chest sounds, and the healthcare system needs a practical way to capture this data and put it to work for the benefit of patients,” said Opauszky. “Stethophone is the tool to do this.”

In trials conducted at Eastern Health Medical Centre, Newfoundland, Canada, 70 percent of medical professionals rated Stethophone superior in diagnostic sound performance over other leading devices. Stethophone also performed significantly higher in overall correct heart pathology diagnosis and correct normal heart diagnosis.

Cardiovascular diseases (CVDs) are the leading cause of death globally, representing 32 percent of all global deaths. The number of people at risk of CVD is on the rise. The American heart association reports that nearly half of all U.S. adults have some type of cardiovascular disease.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy